Preparation and preclinical evaluation of a novel liposomal complete-core lipopolysaccharide vaccine.
about
Anti-endotoxin vaccines: back to the futureLipopolysaccharide endotoxinsEnhanced biofilm formation by Escherichia coli LPS mutants defective in Hep biosynthesisA novel liposome-based nanocarrier loaded with an LPS-dsRNA cocktail for fish innate immune system stimulationLiposome-Encapsulated Bacteriophages for Enhanced Oral Phage Therapy against Salmonella sppImprovement of immunogenicity of meningococcal lipooligosaccharide by coformulation with lipidated transferrin-binding protein B in liposomes: implications for vaccine development.Pseudomonas aeruginosa: the potential to immunise against infection.Comparative genomics of European avian pathogenic E. Coli (APEC).Molecular techniques in the diagnosis and management of infectious diseases: do they have a role in bacteriology?Lipopolysaccharide: a tool and target in enterobacterial vaccine development.Genetic and Functional Diversity of Pseudomonas aeruginosa Lipopolysaccharide.Recent developments for Pseudomonas vaccines.Interaction of W-substituted analogs of cyclo-RRRWFW with bacterial lipopolysaccharides: the role of the aromatic cluster in antimicrobial activity.Naturally produced outer membrane vesicles from Pseudomonas aeruginosa elicit a potent innate immune response via combined sensing of both lipopolysaccharide and protein components.The Role of Carbohydrates in the Lipopolysaccharide (LPS)/Toll-Like Receptor 4 (TLR4) Signalling.Nano/Micro Formulations for Bacteriophage Delivery.
P2860
Q22305428-7BBCC8E8-1A91-424F-B1BC-1DCE5E0A5430Q24650970-E2E3831B-AF2D-4EF7-96AD-7394FA0ACFC7Q34531717-53F2E1C7-228F-4726-B123-E8B70F2E6355Q35034640-04A0906F-281F-470C-A4AF-A0B46BB916C1Q35625761-FA74006F-EBE9-4719-9E5F-CF2B76778AF9Q35940728-8C342D8A-BB5B-4A08-BF80-499C46510ECCQ36194089-C5C8C4AA-A417-4127-8056-423261F77962Q36201311-49DE344C-18E0-443A-8DF2-F09EF9B7B4FEQ36231621-E1EF13C3-DC57-4B05-9046-6DF7A9A65D40Q37309260-C4D35640-09F5-4624-AE29-0D3D6D8F1DC9Q37891784-E0E589C5-F729-4ECA-B09C-BBF1B209BC36Q37937369-0331E62D-4C75-4D43-B809-E45C1D944C98Q38339156-6B620E1A-D356-4D52-AA33-5D56ED00EC08Q42181392-665892D7-9212-441A-9E25-7EB86E16C7B8Q47147061-D418A143-BAF0-4C10-8B36-03FD686F2C4BQ49934113-3982A7A1-4C83-43D0-9F05-D4A19BC78DAB
P2860
Preparation and preclinical evaluation of a novel liposomal complete-core lipopolysaccharide vaccine.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Preparation and preclinical ev ...... re lipopolysaccharide vaccine.
@ast
Preparation and preclinical ev ...... re lipopolysaccharide vaccine.
@en
Preparation and preclinical ev ...... re lipopolysaccharide vaccine.
@nl
type
label
Preparation and preclinical ev ...... re lipopolysaccharide vaccine.
@ast
Preparation and preclinical ev ...... re lipopolysaccharide vaccine.
@en
Preparation and preclinical ev ...... re lipopolysaccharide vaccine.
@nl
prefLabel
Preparation and preclinical ev ...... re lipopolysaccharide vaccine.
@ast
Preparation and preclinical ev ...... re lipopolysaccharide vaccine.
@en
Preparation and preclinical ev ...... re lipopolysaccharide vaccine.
@nl
P2093
P2860
P1476
Preparation and preclinical ev ...... re lipopolysaccharide vaccine.
@en
P2093
D S Snyder
E Bennett-Guerrero
G R Barclay
I R Poxton
M G Mythen
T J McIntosh
P2860
P304
P356
10.1128/IAI.68.11.6202-6208.2000
P407
P577
2000-11-01T00:00:00Z